| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/25/1992 | CA2051749A1 Cell adhesion molecule |
| 03/25/1992 | CA2050826A1 Microbial preparation of 13.beta.-13-deoxy-22,23-dihydro avermectin-b1a/b1b a glycone |
| 03/25/1992 | CA2050817A1 Hiv-neutralizing rat monoclonal antibodies against pb-1 |
| 03/24/1992 | US5099034 Nervous system and cardiovascular disorders |
| 03/24/1992 | US5098935 Carcinostatic or antitumor antibiotic, conagenin, and production and uses thereof |
| 03/24/1992 | US5098887 Angiotensin converting enzyme inhibitor |
| 03/24/1992 | US5098841 Process for the preparation of hydroxy acids |
| 03/24/1992 | US5098839 DNA sequences |
| 03/24/1992 | US5098837 Recombinant DNA sequence of spiramycin antibiotic biosynthetic gene |
| 03/24/1992 | US5098832 Isolating medium for identifying the salmonella bacterium |
| 03/24/1992 | US5098829 Immunoadsorbents |
| 03/24/1992 | CA1297825C Antibiotics called "chloropolysporins b and c" a process for their preparation, and their therapeutic and veterinary use |
| 03/24/1992 | CA1297824C Spray drying of microorganisms having ice nucleating activity |
| 03/24/1992 | CA1297823C Somatic embryogenesis employing organic acids |
| 03/24/1992 | CA1297819C Hybridoma tumor cell lines and their monoclonal antibodies to theumatin |
| 03/24/1992 | CA1297817C Monoclonal antibody specific to a common determinant site of neutrophilsand eosinophils |
| 03/24/1992 | CA1297816C Platelet function inhibiting monoclonal antibody fragment |
| 03/24/1992 | CA1297815C Fibrinogen blocking monoclonal antibody |
| 03/24/1992 | CA1297814C Process for production of insulin-like growth factor i and plasmid for production thereof |
| 03/24/1992 | CA1297813C Process for production of insulin-like growth factor i |
| 03/24/1992 | CA1297812C Plasmid schuttle vectors conferring spiramycin resistance in streptomyces |
| 03/22/1992 | CA2051829A1 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis |
| 03/22/1992 | CA2051796A1 Vascular endothelial cell growth factor ii |
| 03/19/1992 | WO1992005273A1 Gene therapy for cystic fibrosis |
| 03/19/1992 | WO1992004461A1 Genetically engineered coccidiosis vaccine |
| 03/19/1992 | WO1992004452A1 Transcription initiation regulating nucleotide sequence |
| 03/19/1992 | WO1992004451A1 Promoter probe vectors, able to replicate in e.coli, b.subtilis, lactococci and lactobacillus as well as uses thereof |
| 03/19/1992 | WO1992004449A1 Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
| 03/19/1992 | WO1992004448A2 Human mitochondrial nad(p)+-dependent malate enzyme |
| 03/19/1992 | WO1992004380A1 Specific binding agents |
| 03/19/1992 | WO1992004363A1 Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| 03/19/1992 | WO1992004050A1 Recombinant herpes simplex viruses vaccines and methods |
| 03/19/1992 | WO1992004037A1 Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic |
| 03/19/1992 | WO1992002612A3 Tissue plasminogen activator variants with decreased clearance |
| 03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
| 03/19/1992 | CA2090010A1 Nucleotidic sequence regulating the initiation of transcription |
| 03/18/1992 | WO1992005191A1 Fungicidally active compounds |
| 03/18/1992 | EP0475842A1 Expression cassette of a precursor of endothiapepsin in Cryhonectria parasitica |
| 03/18/1992 | EP0475746A1 Human and murine interleukin-5 receptor |
| 03/18/1992 | EP0475719A2 Platelet derived growth regulating peptide |
| 03/18/1992 | EP0475706A1 Novel squalene synthetase inhibitors |
| 03/18/1992 | EP0475656A2 The use of Bacillus thuringiensis microbes for controlling the lesser mealworm Alphitobius diaperinus |
| 03/18/1992 | EP0475652A2 Cephalosporin C acylase |
| 03/18/1992 | EP0475623A1 Genetic mechanisms of tumor supression |
| 03/18/1992 | EP0475518A1 28-Hydroxy ivermectin aglycone |
| 03/18/1992 | EP0475354A2 Sialysation of glycoproteins by genetic technology |
| 03/18/1992 | EP0475311A1 Process for removing proteins originating from Escherichia coli |
| 03/18/1992 | EP0475304A1 Method for identifying and/or isolating genes which code for membrane receptors |
| 03/18/1992 | EP0475195A2 Cloning of Sac II restriction endonuclease and methylase |
| 03/18/1992 | EP0474979A1 Heparin binding neurotrophic factor gene sequence |
| 03/18/1992 | EP0474868A1 Method of producing core structure of retro virus and particle produced thereby |
| 03/18/1992 | EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides. |
| 03/18/1992 | EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
| 03/18/1992 | EP0474646A1 Bordetella vaccines |
| 03/18/1992 | EP0420894A4 Large scale method for purification of high purity heparinase |
| 03/18/1992 | EP0303625B1 Polypeptide competitor for immunoglobulin e |
| 03/18/1992 | EP0216786B1 Purification, production and use of tumor necrosis factors |
| 03/18/1992 | CN1015908B Process for the preparation of cellulose film, cellulose film produced thereby, artificial skin graft and its use |
| 03/18/1992 | CA2091905A1 Fungicidally active compounds |
| 03/17/1992 | US5096924 Antitumor agent; isochromene derivative |
| 03/17/1992 | US5096922 Sorangicin antibiotics |
| 03/17/1992 | US5096884 Glidobactin pf-1 peptide antibiotics |
| 03/17/1992 | US5096819 Hyperproduction of poly-β-hydroxybutyrate during exponential growth by mutant strains of Azotobacter vinelandii |
| 03/17/1992 | US5096815 Generation and selection of novel dna-binding proteins and polypeptides |
| 03/17/1992 | CA1297635C Protein purification |
| 03/17/1992 | CA1297439C Process for producing compounds containing a terminal hydroxyl or epoxy group; and microorganisms suitable therefor |
| 03/17/1992 | CA1297438C Transformation of yeasts of the genus pichia |
| 03/17/1992 | CA1297437C Process for the preparation of protease inhibitors |
| 03/17/1992 | CA1297436C Eucaryotic expression system |
| 03/17/1992 | CA1297435C Messenger rna stabilization in animal cells |
| 03/17/1992 | CA1297434C Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same |
| 03/17/1992 | CA1297433C Spiramycin resistance-conferring cloning vectors |
| 03/15/1992 | WO1992005198A1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS |
| 03/15/1992 | CA2091266A1 Expression of macrophage inducible proteins (mips) in yeast cells |
| 03/15/1992 | CA2051171A1 Lipase-surface complex and methods of formation and use |
| 03/14/1992 | WO1992005249A1 Lipase variants |
| 03/14/1992 | CA2092615A1 Lipase variants |
| 03/14/1992 | CA2050739A1 Squalene synthetase inhibitors |
| 03/13/1992 | CA2050721A1 28-hydroxy ivermectin aglycone |
| 03/12/1992 | WO1992004381A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 03/12/1992 | CA2091335A1 Antibodies for treatment and prevention of infection in animals and man |
| 03/12/1992 | CA2051051A1 Cassette for the expression of an endothiapepsin precursor in cryphonectria parastica |
| 03/12/1992 | CA2051047A1 Glycoprotein sialylation by gene manipulation |
| 03/12/1992 | CA2051044A1 Cytostatic agent |
| 03/12/1992 | CA2049214A1 Use of bacillus thuringiensis microbes for controlling the lesser mealworm, alphitobius diaperinus |
| 03/11/1992 | EP0474601A2 Expression of genes encoding plant pathogenesis related proteins in plant associated bacteria |
| 03/11/1992 | EP0474347A1 Astaxanthin-generating yeast cells |
| 03/11/1992 | EP0474313A2 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations |
| 03/11/1992 | EP0474182A2 Method for the purification of a bifidobacteria-proliferating substance |
| 03/11/1992 | EP0474116A1 Stable 6-phosphogluconolactonase, method of its production and its use |
| 03/11/1992 | EP0474046A1 1-Kestose and method of producing the same |
| 03/11/1992 | EP0473725A1 Composition and method to detect sensitivity to alpha interferon therapy |
| 03/11/1992 | EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 03/11/1992 | EP0473716A1 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 03/11/1992 | EP0473700A1 An enzyme-catalyzed process for preparing n-acyl amino acids and n-acyl amino acid amides |
| 03/11/1992 | EP0454820A4 A83543 recovery process |
| 03/11/1992 | EP0435877A4 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 03/11/1992 | EP0431042A4 A method of preparing an active human neutrophil chemotactic factor polypeptide |
| 03/11/1992 | EP0394352B1 Enzymatic detergent |
| 03/11/1992 | EP0205506B1 A method of transforming fungi with a vector |